Aethlon Medical's Blood-Filtering Ebola Device Ready For Testing
A new Ebola treatment device known as the Aethlon Hemopurifier is scheduled to begin U.S. clinical trials by the end of this year, after receiving the green light for trials from the FDA. The device received significant backing following news of a German patient suffering from Ebola that was declared free of the virus, and on the road to a complete recovery.
In a recent news release from Aethlon Medical Inc, the company describes the device as a first-in-class biofiltration device that targets the rapid elimination of viruses and immunosuppressive proteins from the circulatory system of infected individuals.
Help employers find you! Check out all the jobs and post your resume.
In a recent news release from Aethlon Medical Inc, the company describes the device as a first-in-class biofiltration device that targets the rapid elimination of viruses and immunosuppressive proteins from the circulatory system of infected individuals.
Help employers find you! Check out all the jobs and post your resume.